Period: Dec 15, 2015 to Jan 9, 2017
Lead Plaintiff Deadline: Mar 28, 2017
Summary of Case:
A securities class action has been filed against Egalet Corporation ("Egalet") (NASDAQ:EGLT) on behalf of all persons who purchased or otherwise acquired shares of Egalet between December 15, 2015 through January 9, 2017. This case has been filed in the USDC - Eastern District of Pennsylvania .
The complaint alleges that, among other allegations, throughout the Class Period, Egalet made materially false and/or misleading statements concerning its lead product, ARYMO ER and the likelihood the product would receive oral abuse-deterrent labeling.
If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.